BLAU FARMACÊUTICA S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.53 BRL | +1.87% |
|
-2.41% | -35.83% |
| 20/03 | Transcript : Blau Farmacêutica S.A., Q4 2023 Earnings Call, Mar 20, 2024 | |
| 19/03 | Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2024 * | 1.61B 318M 26.49B | Sales 2025 * | 1.81B 356M 29.72B | Capitalization | 1.87B 369M 30.8B |
|---|---|---|---|---|---|
| Net income 2024 * | 207M 40.85M 3.41B | Net income 2025 * | 267M 52.69M 4.4B | EV / Sales 2024 * | 1.35 x |
| Net Debt 2024 * | 302M 59.57M 4.97B | Net Debt 2025 * | 375M 73.98M 6.17B | EV / Sales 2025 * | 1.24 x |
| P/E ratio 2024 * |
9.01
x | P/E ratio 2025 * |
7.48
x | Employees | 1,900 |
| Yield 2024 * |
2.67% | Yield 2025 * |
3.2% | Free-Float | 16.44% |
More Fundamentals
* Assessed data
More news
Latest transcript on Blau Farmacêutica S.A.
More press releases
| 1 day | +1.87% | ||
| 1 week | -2.41% | ||
| Current month | +4.57% | ||
| 1 month | -13.62% | ||
| 3 months | -11.06% | ||
| 6 months | -37.13% | ||
| Current year | -35.83% |
1 week
9.29
10.90
1 month
9.2912.16
Current year
9.2916.42
1 year
9.2922.56
3 years
9.2954.92
5 years
9.2954.92
10 years
9.2954.92
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | - | 18/87/18 | |
| Director of Finance/CFO | - | 01/18/01 | |
Roberto Altieri
CMP | Compliance Officer | - | 01/14/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | - | |
| Chief Operating Officer | 58 | - | |
| Founder | - | 18/87/18 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.67% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/24/03 | 10.53 | +3.03% | 387,600 |
| 02/24/02 | 10.22 | +1.49% | 369,300 |
| 30/24/30 | 10.07 | -5.45% | 1,501,900 |
| 29/24/29 | 10.65 | -1.30% | 312,700 |
| 26/24/26 | 10.79 | +5.78% | 359,700 |
Delayed Quote Sao Paulo, May 04, 2024 at 01:37 am IST
More quotes
Blau Farmaceutica SA is a Brazil-based company engaged in the pharmaceuticals sector. The Company focuses on the development, production and commercialization of medicines, which aim at treatment in the areas of oncology, nephrology, hematology and infectology, among others. Its product lines includes biopharmaceuticals, biosimilars, oncological - injectable, oncological - oral, blood products, antiviral and antiretrovirals, uterine stimulators, anaesthetics, antithrombotics, thrombolytics, female health care, antibiotics, non-beta lactams, cephalosporin, chloramphenicol, acid pumper inhibitor and other hospital products. The Company operates in Brazil, Argentina, Colombia, Peru, Uruguay, Chile and the United States, having a pharmaceutical industrial complex composed of five industrial plants, dedicated to the production of biological, biotechnological and oncological medicines, antibiotics, injectable anesthetics and biotechnological inputs.
Sector
Pharmaceuticals
Calendar
07/05/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
7
Last Close Price
10.53
BRL
Average target price
14.29
BRL
Spread / Average Target
+35.67%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -35.83% | 369M | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B | |
| -3.40% | 157B |
- Stock Market
- Equities
- BLAU3 Stock
